6W5C image
Deposition Date 2020-03-13
Release Date 2020-09-16
Last Version Date 2024-03-06
Entry Detail
PDB ID:
6W5C
Title:
Cryo-EM structure of Cas12i(E894A)-crRNA-dsDNA complex
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Cas12i
Chain IDs:A
Chain Length:1092
Number of Molecules:1
Biological Source:Lachnospiraceae bacterium ND2006
Polymer Type:polyribonucleotide
Molecule:crRNA
Chain IDs:E (auth: B)
Chain Length:59
Number of Molecules:1
Biological Source:Escherichia coli
Polymer Type:polydeoxyribonucleotide
Molecule:TS
Chain IDs:B (auth: C)
Chain Length:36
Number of Molecules:1
Biological Source:Lachnospiraceae bacterium ND2006
Polymer Type:polydeoxyribonucleotide
Molecule:NTS
Chain IDs:C (auth: D)
Chain Length:10
Number of Molecules:1
Biological Source:Lachnospiraceae bacterium ND2006
Polymer Type:polydeoxyribonucleotide
Molecule:Substrate
Chain IDs:D (auth: E)
Chain Length:9
Number of Molecules:1
Biological Source:Lachnospiraceae bacterium ND2006
Primary Citation
Mechanisms for target recognition and cleavage by the Cas12i RNA-guided endonuclease.
Nat.Struct.Mol.Biol. 27 1069 1076 (2020)
PMID: 32895556 DOI: 10.1038/s41594-020-0499-0

Abstact

Cas12i is a recently identified type V CRISPR-Cas endonuclease that predominantly cleaves the non-target strand of a double-stranded DNA substrate. This nicking activity of Cas12i could potentially be used for genome editing with high specificity. To elucidate its mechanisms for target recognition and cleavage, we determined cryo-EM structures of Cas12i in multiple functional states. Cas12i pre-orders a seven-nucleotide seed sequence of the crRNA for target recognition and undergoes a two-step activation through crRNA-DNA hybridization. Formation of 14 base pairs activates the nickase activity, and 28-bp hybridization promotes cleavage of the target strand. The atomic structures and mechanistic insights gained should facilitate the manipulation of Cas12i for genome editing applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures